Suppr超能文献

伴有肝硬化的肝细胞癌行肝大部切除术后的医院死亡率

Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.

作者信息

Fan S T, Lai E C, Lo C M, Ng I O, Wong J

机构信息

Department of Surgery, University of Hong Kong, Queen Mary Hospital.

出版信息

Arch Surg. 1995 Feb;130(2):198-203. doi: 10.1001/archsurg.1995.01430020088017.

Abstract

OBJECTIVE

To define the safety of major hepatectomy for hepatocellular carcinoma (HCC) associated with cirrhosis and the selection criteria for surgery in terms of hospital mortality.

DESIGN

Major hepatectomy for HCC in the presence of cirrhosis is considered to be contraindicated by many surgeons because the reported mortality rate is high (26% to 50%). Previous workers recommended that only selected patients with Child's A status or indocyanine green (ICG) retention at 15 minutes of less than 10% undergo major hepatectomy. A survey was made, therefore, of our patients with HCC and cirrhosis undergoing major hepatectomy between 1989 and 1994.

SETTING

A tertiary referral center.

PATIENTS

The preoperative, intraoperative, and postoperative data of 54 patients with cirrhosis who had major hepatectomy were compared with those of 25 patients with underlying chronic active hepatitis and 22 patients with normal livers undergoing major hepatectomy for HCC. The data had been prospectively collected.

INTERVENTION

Major hepatectomy, defined as resection of two or more liver segments by Goldsmith and Woodburn nomenclature, was performed on all the patients.

MAIN OUTCOME MEASURE

Hospital mortality, which was defined as death within the same hospital admission for the hepatectomy.

RESULTS

Preoperative liver function in patients with cirrhosis was worse than in those with normal livers. The intraoperative blood loss was also higher (P = .01), but for patients with cirrhosis, chronic active hepatitis, and normal livers, the hospital mortality rates (13%, 16%, and 14%, respectively) were similar. The hospital mortality rate for patients with cirrhosis in the last 2 years of the study was only 5%. Patients with cirrhosis could tolerate up to 10 L of blood loss and survive the major hepatectomy. By discriminant analysis, an ICG retention of 14% at 15 minutes was the cutoff level that could maximally separate the patients with cirrhosis with and without mortality.

CONCLUSION

Major hepatectomy for HCC in the presence of cirrhosis is associated with a mortality rate that is not different from the rate for patients with normal livers. An ICG retention of 14% at 15 minutes would serve as a better selection criterion than the 10% previously used.

摘要

目的

明确肝硬化合并肝细胞癌(HCC)患者接受肝大部切除术的安全性以及基于医院死亡率的手术选择标准。

设计

许多外科医生认为,肝硬化患者行HCC肝大部切除术存在禁忌,因为报道的死亡率较高(26%至50%)。既往研究人员建议,仅选择Child A级或15分钟吲哚菁绿(ICG)潴留率低于10%的患者进行肝大部切除术。因此,我们对1989年至1994年间接受肝大部切除术的HCC合并肝硬化患者进行了一项调查。

地点

一家三级转诊中心。

患者

将54例接受肝大部切除术的肝硬化患者的术前、术中和术后数据与25例潜在慢性活动性肝炎患者以及22例因HCC接受肝大部切除术的正常肝脏患者的数据进行比较。这些数据是前瞻性收集的。

干预

所有患者均接受肝大部切除术,根据Goldsmith和Woodburn命名法,肝大部切除术定义为切除两个或更多肝段。

主要观察指标

医院死亡率,定义为肝大部切除术后同一住院期间内死亡。

结果

肝硬化患者的术前肝功能比正常肝脏患者差。术中失血量也更高(P = 0.01),但肝硬化患者、慢性活动性肝炎患者和正常肝脏患者的医院死亡率分别为13%、16%和14%,相似。研究最后2年肝硬化患者的医院死亡率仅为5%。肝硬化患者能够耐受高达10 L的失血量并在肝大部切除术后存活。通过判别分析,15分钟时ICG潴留率为14%是最大程度区分有或无死亡的肝硬化患者的临界值。

结论

肝硬化合并HCC患者行肝大部切除术的死亡率与正常肝脏患者的死亡率无差异。15分钟时ICG潴留率为14%可作为比先前使用的10%更好的选择标准。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验